Diane Gardiner
Corporate Officer/Principal chez BC Human Resources Management Association
Profil
Diane Gardiner is a member of BC Human Resources Management Association and BC Human Resources Tech Group.
She previously worked as Director-Human Resources at AnorMED, Inc. from 1999 to 2006, Director-Human Resources at LifeLabs, Inc., Senior VP-Human Resources & Administration at Sierra Oncology, Inc., Vice President-Human Resources at Arbutus Biopharma Corp.
from 2013 to 2015, Head-Human Resources at Aquinox Pharmaceuticals, Inc. from 2010 to 2013, and Vice President-Human Resources at The Centre for Drug Research & Development from 2007 to 2010.
She obtained an undergraduate degree from Simon Fraser University.
Postes actifs de Diane Gardiner
| Sociétés | Poste | Début |
|---|---|---|
| BC Human Resources Management Association | Corporate Officer/Principal | - |
| BC Human Resources Tech Group | Corporate Officer/Principal | - |
Anciens postes connus de Diane Gardiner
| Sociétés | Poste | Fin |
|---|---|---|
| SIERRA ONCOLOGY, INC. | Directeur Administratif | 01/07/2022 |
| ARBUTUS BIOPHARMA CORPORATION | Responsable des Ressources Humaines | 01/03/2015 |
Aquinox Pharmaceuticals, Inc.
 Aquinox Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aquinox Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. It discovers and develops targeted therapeutics for inflammation and immuno-oncology. It also focuses on anti-inflammatory product candidates targeting SHIP1, which is a key regulator of an important cellular signaling pathway in immune cells, known as the PI3K pathway. The company was founded by Raymond J. Andersen, David J. Main, Low Fung Mui, Christopher John Ong, and Gerald Krystal on December 26, 2003 and is headquartered in Vancouver, Canada. | Responsable des Ressources Humaines | 01/02/2013 |
The Centre for Drug Research & Development
 The Centre for Drug Research & Development Miscellaneous Commercial ServicesCommercial Services Center for Drug Research & Development operates as a drug development and commercialization company. The firm provides the specialized expertise and infrastructure to identify, validate and advance promising discoveries, and transform them into commercially viable investment opportunities for the private sector and ultimately into new therapies for patients. The company was founded in 2007 and is headquartered in Vancouver, Canada. | Responsable des Ressources Humaines | 01/09/2010 |
AnorMED, Inc.
 AnorMED, Inc. Pharmaceuticals: MajorHealth Technology AnorMED is a chemistry-based biopharmaceutical company focused on the discovery, development and commercialization of new therapeutic products in the areas of hematology, HIV and oncology. The Company has four products in clinical development and a research program focused on a novel class of compounds that target specific chemokine receptors known to be involved in a variety of diseases. | Responsable des Ressources Humaines | 01/01/2006 |
Formation de Diane Gardiner
| Simon Fraser University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ARBUTUS BIOPHARMA CORPORATION | Health Technology |
| Entreprise privées | 7 |
|---|---|
AnorMED, Inc.
AnorMED, Inc. Pharmaceuticals: MajorHealth Technology AnorMED is a chemistry-based biopharmaceutical company focused on the discovery, development and commercialization of new therapeutic products in the areas of hematology, HIV and oncology. The Company has four products in clinical development and a research program focused on a novel class of compounds that target specific chemokine receptors known to be involved in a variety of diseases. | Health Technology |
Sierra Oncology, Inc.
 Sierra Oncology, Inc. BiotechnologyHealth Technology Sierra Oncology, Inc. was a clinical stage drug development company of therapeutics for the treatment of cancer. The firm focused on advanced targeted therapeutics for the treatment of patients with significant unmet medical needs in hematology and oncology. Its product Momelotinib, a selective and orally-bioavailable JAK1, JAK2 & ACVR1 inhibitor with a differentiated therapeutic profile in myelofibrosis encompassing robust constitutional symptom improvements. The company was founded in May 2003 and is headquartered in San Mateo, CA. | Health Technology |
LifeLabs, Inc.
 LifeLabs, Inc. Miscellaneous Commercial ServicesCommercial Services LifeLabs, Inc. provides laboratory testing services. It provides specialized clinical laboratory testing, hospital laboratory services, occupational health services, clinical studies services, online kit ordering services. The firm helps physicians and other healthcare providers in prevention, diagnosis, treatment and monitoring of disease and illness in patients. The company was founded in 1969 and is headquartered in Toronto, ON. | Commercial Services |
Aquinox Pharmaceuticals, Inc.
Aquinox Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aquinox Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. It discovers and develops targeted therapeutics for inflammation and immuno-oncology. It also focuses on anti-inflammatory product candidates targeting SHIP1, which is a key regulator of an important cellular signaling pathway in immune cells, known as the PI3K pathway. The company was founded by Raymond J. Andersen, David J. Main, Low Fung Mui, Christopher John Ong, and Gerald Krystal on December 26, 2003 and is headquartered in Vancouver, Canada. | Health Technology |
| BC Human Resources Management Association | |
| BC Human Resources Tech Group | |
The Centre for Drug Research & Development
The Centre for Drug Research & Development Miscellaneous Commercial ServicesCommercial Services Center for Drug Research & Development operates as a drug development and commercialization company. The firm provides the specialized expertise and infrastructure to identify, validate and advance promising discoveries, and transform them into commercially viable investment opportunities for the private sector and ultimately into new therapies for patients. The company was founded in 2007 and is headquartered in Vancouver, Canada. | Commercial Services |